Investing

Published September 23, 2026

Psyence BioMed invests up to $5M in PsyLabs, plans ibogaine trial - Investing.com

Read the full story at Investing

ibogaine . Psyence BioMed stated it is evaluating the feasibility and design of a potential ibogaine clinical trial in Texas for Opioid Use.